CVS Q3 Tops Estimates as Retail Revenues Gain

CVS Q3 Tops Estimates as Retail Revenues Gain

Third quarter earnings and income at CVS Health beat Wall Street estimates despite unadjusted losses from an opioid litigation settlement. Company net loss was $3.42 billion, or $2.60 per diluted share, versus net income of $1.6 billion, or $1.20 per diluted share, in...
CVS Q3 Tops Estimates as Retail Revenues Gain

CVS Beats Expections in Q2

As the company continues on its reorganization as a community well resource, CVS Health beat Wall Street estimates on earnings and revenues while posting a strong comparable sales gain in the retail business. Company net income was $2.95 billion, or $2.23 per diluted...
CVS Q3 Tops Estimates as Retail Revenues Gain

Ostafin Appointed CVS Chief Strategy Officer

CVS Health has announced that Violetta Ostafin will join the company as executive vp and chief strategy officer as it looks to spur growth.  Ostafin will lead strategy development across CVS core businesses as well as identify new market opportunities and product...